Abbas AK,Trotta EDRS,Marson A,Bluestone JA .2018 .Revisiting IL-2: Biology and therapeutic prospects. Science Immunology, 3(25) : eaat1482.
Alkreathy HM,Esmat A .2022 .Lycorine ameliorates thioacetamide-induced hepatic fibrosis in rats: Emphasis on antioxidant, anti-inflammatory, and STAT3 inhibition effects. Pharmaceuticals (Basel), 15(3) : 369.
Ayuso C,Rimola J,Vilana R,Burrel M,Darnell A,García-Criado Á,Bianchi L,Belmonte E,Caparroz C,Barrufet M,Bruix J,Bru C .2018 .Diagnosis and staging of hepatocellular carcinoma (HCC): Current guidelines. Eur. J. Radiol., 101 : 72-81.
Bae J,Liu L,Moore C,Hsu E,Zhang A,Ren Z,Sun Z,Wang X,Zhu J,Shen J,Qiao J,Fu YX .2022 .IL-2 delivery by engineered mesenchymal stem cells reinvigorates CD8+ T cells to overcome immunotherapy resistance in cancer. Nat. Cell Biol, 24(12) : 1754-1765.
Cai MN,Chen DM,Xiao LX,Li SS,Liao CH,Li J,Huang ZX,Wang JL,Gu YR,Gu L,Huang YH,Lian YF .2023 .COLEC10 induces endoplasmic reticulum stress by occupying GRP78 and inhibits hepatocellular carcinoma. Lab. Invest, 103(7) : 100130.
Chedid MF,Kruel CRP,Pinto MA,Grezzana-Filho TJM,Leipnitz I,Kruel CDP,Scaffaro LA,Chedid AD .2017 .Hepatocellular carcinoma: Diagnosis and operative management. Arquivos brasileiros de cirurgia digestiva: ABCD = Brazilian archives of digestive surgery. , 30(4) : 272-278.
Chen T,You Y,Jiang H,Wang ZZ H .2017 .Epithelialmesenchymal transition (EMT): A biological process in the development, stem cell differentiation and tumorigenesis. J. Cell Physiol, 232(12) : 3261-3272.
Cruceriu D,Baldasici O,Balacescu O,BerindanNeagoe I .2020 .The dual role of tumor necrosis factor-alpha (TNF-α) in breast cancer: Molecular insights and therapeutic approaches. Cell Oncol, 43(1) : 1-18.
Sotto Di,Valipour A,Azari M,Di A,Irannejad H Giacomo S .2023 .Benzoindolizidine alkaloids tylophorine and lycorine and their analogues with antiviral, anti-inflammatory, and anticancer properties: Promises and challenges. Biomedicines, 11(10) : 2619.
Diener C,Keller A,Meese E .2022 .Emerging concepts of miRNA therapeutics: From cells to clinic. Trends Genet, 38(6) : 613-626.
Ding H,Wang G,Yu Z,Sun H,Wang L H .2022 .Role of interferon-gamma (IFN-γ) and IFN-γ receptor 1/2 (IFNγR1/2) in regulation of immunity, infection, and cancer development: IFN-γ-dependent or independent pathway. Biomed, 155 : 113683.
Foglia B,Turato C,Cannito S C .2023 .Hepatocellular carcinoma: Latest research in pathogenesis, detection and treatment. Int. J. Mol. Sci, 24(15) : 12224.
Hartke J,Johnson M,Ghabril M M .2017 .The diagnosis and treatment of hepatocellular carcinoma. Semin. Diagn. Pathol., 34(2) : 153-159.
Hassanipour S,Vali M,Gaffari-Fam S,Nikbakht HA,Abdzadeh E,Joukar F,Pourshams A,Shafaghi A,Malakoutikhah M,Arab-Zozani M,Salehiniya H,Mansour-Ghanaei F .2020 .The survival rate of hepatocellular carcinoma in Asian countries: A systematic review and meta-analysis. EXCLI Journal, 19 : 108-130.
He B,Zhao Z,Cai Q,Zhang Y,Zhang P,Shi S,Xie H,Peng X,Yin W,Tao Y,Wang X Y .2020 .miRNAbased biomarkers, therapies and resistance in Cancer. Int J Biol Sci., 16(14) : 2628-2647.
Hu M,Yu Z,Mei P,Li J,Luo D,Zhang H,Zhou M,Liang F,Chen R F .2020 .Lycorine Induces autophagy-associated apoptosis by targeting MEK2 and enhances vemurafenib activity in colorectal cancer. Aging, 12(1) : 138-155.
Hu Z,Zhao Y,Mang Y,Zhu J,Yu L,Li L,Ran J .2023 .MiR-21-5p promotes sorafenib resistance and hepatocellular carcinoma progression by regulating SIRT7 ubiquitination through USP24. Life Sciences, 325 : 121773.
Jorgovanovic D,Song M,Wang L,Zhang Y .2020 .Roles of IFN-γ in tumor progression and regression: A review. Biomarker research, 8 : 49.
Li D,Zhang J,Li J .2020 .Role of miRNA sponges in hepatocellular carcinoma. Clin. Chim. Acta., 500 : 10-19.
Li Y,Jiang A .2020 .ST8SIA6-AS1 promotes hepatocellular carcinoma by absorbing miR-5195-3p to regulate HOXB6. Cancer Biol Ther. , 21 : 647-655.
Li Z,Zhou Q,Liu X,Li Y,Fan X,Liu G .2022 .Lycorine upregulates the expression of RMB10, promotes apoptosis and inhibits the proliferation and migration of cervical cancer cells. Int. J. Mol. Med, 50(6) : 145.
Li Z,Wu L,Tan W,Zhang K,Lin Q,Zhu J,Tu C,Lv X,Jiang C .2021 .MiR-20b-5p promotes hepatocellular carcinoma cell proliferation, migration and invasion by down-regulating CPEB3. , 23 : 100345.
Mittal V .2018 .Epithelial mesenchymal transition in tumor metastasis. Annu. Rev. Pathol., 13 : 395-412.
Nagaraju GP,Dariya B,Kasa P,Peela S,El-Rayes BF .2022 .Epigenetics in hepatocellular carcinoma. Semin. Cancer Biol, 86 : 622-632.
Oura K,Morishita A,Masaki T .2020 .Molecular and functional roles of MicroRNAs in the progression of hepatocellular carcinoma - A review. Int. J. Mol. Sci, 21(21) : 8362.
Oura K,Morishita A,Tani J,Masaki T .2021 .Tumor immune microenvironment and immunosuppressive therapy in hepatocellular carcinoma: A review. Int. J. Mol. Sci, 22(11) : 5801.
Pallasch FB,Schumacher U .2020 .Angiotensin inhibition, TGF-β and EMT in cancer. Cancers, 12(10) : 2785.
Roy M,Liang L,Xiao X,Feng P,Ye M,Liu J .2018 .Lycorine: A prospective natural lead for anticancer drug discovery. Biomed, 107 : 615-624.
Sartorius K,Sartorius B,Winkler C,Chuturgoon A,Makarova J .2018 .The biological and diagnostic role of miRNA's in hepatocellular carcinoma. Frontiers in bioscience (Landmark edition), 23(9) : 1701-1720.
Shen J,Zhang T,Cheng Z,Zhu N,Wang H,Lin L,Wang Z,Yi H,Hu M H .2018 .Lycorine inhibits glioblastoma multiforme growth through EGFR suppression. J. Exp. Clin. Cancer Res., 37(1) : 157.
Sun Y,Gu Y,Gao X,Jin X,Wink M,Sharopov FS,Yang L,Sethi G .2023 .Lycorine suppresses the malignancy of breast carcinoma by modulating epithelial mesenchymal transition and β-catenin signaling. Pharmacol. Res., 195 : 106866.
Wang F,Xie Z,Zhang N,Ding H,Xiong K,Guo L,Huang H,Wen Z H .2022 .Has_circ_0008583 modulates hepatocellular carcinoma progression through the miR-1301-3p/METTL3 pathway. , 13 : 1185-1197.
Wang N,Li P,Liu J,Wang Z J .2023 .MiR-29a-3p promotes nasal epithelial barrier dysfunction via direct targeting of CTNNB1-VCL module in allergic rhinitis. Int. Immunopharmacol., 120 : 110325.
Wang Y,Wang P,Zhao L,Chen X,Lin Z,Zhang L,Li Z L .2021 .Front Cell Dev Biol. , 9 : 679185.
Wen NY,Cai YL,Li FY,Ye H,Tang W,Cheng NS W .2022 .The clinical management of hepatocellular carcinoma worldwide: A concise review and comparison of current guidelines: 2022 update. Biosci. Trends, 16(1) : 20-30.
Wu F,Yang J,Shang G,Zhang Z,Niu S,Liu Y,Liu H,Jing J,Fang Y .2022 .Exosomal miR-224-5p from colorectal cancer cells promotes malignant transformation of human normal colon epithelial cells by promoting cell proliferation through downregulation of CMTM4. Oxid. Med, 5983629 : .
Xu J,Wang Y,Jiang J,Yin C,Shi B C .2023 .ADAM12 promotes clear cell renal cell carcinoma progression and triggers EMT via EGFR/ERK signaling pathway. J. Transl. Med, 21(1) : 56.
Yu H,Qiu Y,Pang X,Li J,Wu S,Yin S,Han L,Zhang Y,Jin C,Gao X,Hu W,Wang T .2017 .Lycorine promotes autophagy and apoptosis via TCRP1/Akt/mTOR axis inactivation in human hepatocellular carcinoma. Mol. Cancer Ther, 16(12) : 2711-2723.
Zang CS,Huang HT,Qiu J,Sun J,Ge RF,Jiang LW .2020 .MiR-224-5p targets EGR2 to promote the development of papillary thyroid carcinoma. Eur. Rev. Med, 24(9) : 4890-4900.
Zhai J,Jiang JF,Shi L JF .2023 .Lycorine weakens tamoxifen resistance of breast cancer via abrogating HAGLR-mediated epigenetic suppression on VGLL4 by DNMT1. Kaohsiung J Med Sci., 39 : 278-289.
Zhang L,Huang L,Liang H,Zhang R,Chen G,Pang Y,Feng Z Y .2017 .Clinical value and potential targets of miR-224-5p in hepatocellular carcinoma validated by a TCGA- and GEO- based study. Int. J. Clin. Exp, 10(9) : 9970-9989.
Zhou J,Wang H,Sun Q,Liu X,Wu Z,Wang X,Fang W,- W .2021 .-enriched exosomes promote tumorigenesis by directly targeting androgen receptor in non-small cell lung cancer. Mol. Ther. Nucleic Acids, 23 : 1217-1228.